vs
Palladyne AI Corp.（PDYN）与Roivant Sciences Ltd.（ROIV）财务数据对比。点击上方公司名可切换其他公司
Roivant Sciences Ltd.的季度营收约是Palladyne AI Corp.的1.2倍（$2.0M vs $1.7M），Palladyne AI Corp.净利率更高（-89.9% vs -13301.2%，领先13211.3%），Palladyne AI Corp.同比增速更快（118.3% vs -77.8%），Palladyne AI Corp.自由现金流更多（$-8.7M vs $-201.4M），过去两年Palladyne AI Corp.的营收复合增速更高（-30.5% vs -73.7%）
Palladyne AI Corp是一家美国企业，其前身1983年成立时名为萨科斯研究公司，企业长期以来以机器人开发为核心业务。2023年，公司调整业务方向，专注开发适用于机器人场景的人工智能软件，终止了硬件业务，并于2024年3月正式更名为现用名。
Roivant Sciences Ltd.是一家美国跨国医疗健康企业，2014年由维韦克·拉马斯瓦米创立，现任CEO为马特·格林。公司专注于将技术应用于药物研发领域，同时孵化运营多家生命科学与健康科技子公司，总部位于纽约，在波士顿、巴塞尔两大生物科技产业集群也设有核心办公点。
PDYN vs ROIV — 直观对比
营收规模更大
ROIV
是对方的1.2倍
$1.7M
营收增速更快
PDYN
高出196.1%
-77.8%
净利率更高
PDYN
高出13211.3%
-13301.2%
自由现金流更多
PDYN
多$192.7M
$-201.4M
两年增速更快
PDYN
近两年复合增速
-73.7%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.7M | $2.0M |
| 净利润 | $-1.5M | $-265.9M |
| 毛利率 | 15.6% | — |
| 营业利润率 | -560.7% | -16966.1% |
| 净利率 | -89.9% | -13301.2% |
| 营收同比 | 118.3% | -77.8% |
| 净利润同比 | 97.2% | -257.0% |
| 每股收益（稀释后） | $-0.02 | $-0.38 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PDYNROIV
| Q4 25 | $1.7M | $2.0M | ||
| Q3 25 | $860.0K | $1.6M | ||
| Q2 25 | $1.0M | $2.2M | ||
| Q1 25 | $1.7M | $-39.6M | ||
| Q4 24 | $761.0K | $9.0M | ||
| Q3 24 | $871.0K | $4.5M | ||
| Q2 24 | $2.7M | $8.0M | ||
| Q1 24 | $3.4M | $28.9M |
净利润PDYNROIV
| Q4 25 | $-1.5M | $-265.9M | ||
| Q3 25 | $-3.7M | $-113.5M | ||
| Q2 25 | $-7.5M | $-223.4M | ||
| Q1 25 | $22.8M | $-206.5M | ||
| Q4 24 | — | $169.4M | ||
| Q3 24 | $-7.1M | $-230.2M | ||
| Q2 24 | $-5.3M | $95.3M | ||
| Q1 24 | $-7.2M | $-151.1M |
毛利率PDYNROIV
| Q4 25 | 15.6% | — | ||
| Q3 25 | 46.4% | — | ||
| Q2 25 | 53.3% | — | ||
| Q1 25 | 79.4% | — | ||
| Q4 24 | 27.2% | — | ||
| Q3 24 | 45.0% | — | ||
| Q2 24 | 79.0% | — | ||
| Q1 24 | 45.2% | — |
营业利润率PDYNROIV
| Q4 25 | -560.7% | -16966.1% | ||
| Q3 25 | -937.8% | -19492.9% | ||
| Q2 25 | -797.4% | -13130.0% | ||
| Q1 25 | -405.3% | 674.8% | ||
| Q4 24 | — | -3042.6% | ||
| Q3 24 | -838.0% | -7636.0% | ||
| Q2 24 | -213.3% | -1279.5% | ||
| Q1 24 | -213.7% | -919.5% |
净利率PDYNROIV
| Q4 25 | -89.9% | -13301.2% | ||
| Q3 25 | -434.9% | -7225.9% | ||
| Q2 25 | -737.6% | -10292.9% | ||
| Q1 25 | 1330.9% | 521.8% | ||
| Q4 24 | — | 1878.3% | ||
| Q3 24 | -814.7% | -5143.8% | ||
| Q2 24 | -196.2% | 1192.7% | ||
| Q1 24 | -210.1% | -522.3% |
每股收益（稀释后）PDYNROIV
| Q4 25 | $-0.02 | $-0.38 | ||
| Q3 25 | $-0.09 | $-0.17 | ||
| Q2 25 | $-0.20 | $-0.33 | ||
| Q1 25 | $0.55 | $-0.28 | ||
| Q4 24 | — | $0.23 | ||
| Q3 24 | $-0.27 | $-0.31 | ||
| Q2 24 | $-0.20 | $0.12 | ||
| Q1 24 | $-0.28 | $-0.02 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $47.1M | $4.5B |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $74.7M | $4.3B |
| 总资产 | $95.7M | $5.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资PDYNROIV
| Q4 25 | $47.1M | $4.5B | ||
| Q3 25 | $57.1M | $4.4B | ||
| Q2 25 | $62.7M | $4.5B | ||
| Q1 25 | $46.6M | $4.9B | ||
| Q4 24 | $40.1M | $5.1B | ||
| Q3 24 | $21.3M | $5.4B | ||
| Q2 24 | $25.8M | $5.7B | ||
| Q1 24 | $31.8M | $6.5B |
总债务PDYNROIV
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $311.7M | ||
| Q1 24 | — | $430.6M |
股东权益PDYNROIV
| Q4 25 | $74.7M | $4.3B | ||
| Q3 25 | $51.8M | $4.4B | ||
| Q2 25 | $53.8M | $4.3B | ||
| Q1 25 | $28.3M | $4.7B | ||
| Q4 24 | $-9.5M | $5.2B | ||
| Q3 24 | $23.4M | $5.2B | ||
| Q2 24 | $29.8M | $5.4B | ||
| Q1 24 | $34.2M | $6.0B |
总资产PDYNROIV
| Q4 25 | $95.7M | $5.2B | ||
| Q3 25 | $72.9M | $5.1B | ||
| Q2 25 | $78.3M | $5.0B | ||
| Q1 25 | $63.3M | $5.4B | ||
| Q4 24 | $56.3M | $5.8B | ||
| Q3 24 | $38.7M | $6.2B | ||
| Q2 24 | $45.1M | $6.5B | ||
| Q1 24 | $50.4M | $7.2B |
负债/权益比PDYNROIV
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.06× | ||
| Q1 24 | — | 0.07× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-8.5M | $-196.5M |
| 自由现金流经营现金流 - 资本支出 | $-8.7M | $-201.4M |
| 自由现金流率自由现金流/营收 | -526.2% | -10076.0% |
| 资本支出强度资本支出/营收 | 14.2% | 246.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-776.7M |
8季度趋势，按日历期对齐
经营现金流PDYNROIV
| Q4 25 | $-8.5M | $-196.5M | ||
| Q3 25 | $-6.3M | $-185.7M | ||
| Q2 25 | $-5.3M | $-204.4M | ||
| Q1 25 | $-7.5M | $-172.6M | ||
| Q4 24 | $-22.6M | $-207.3M | ||
| Q3 24 | $-4.5M | $-266.8M | ||
| Q2 24 | $-5.8M | $-192.8M | ||
| Q1 24 | $-7.2M | $-108.5M |
自由现金流PDYNROIV
| Q4 25 | $-8.7M | $-201.4M | ||
| Q3 25 | $-6.7M | $-193.5M | ||
| Q2 25 | — | $-208.4M | ||
| Q1 25 | $-7.6M | $-173.4M | ||
| Q4 24 | $-22.9M | $-209.1M | ||
| Q3 24 | $-4.5M | $-267.8M | ||
| Q2 24 | $-5.9M | $-193.8M | ||
| Q1 24 | $-7.3M | $-108.8M |
自由现金流率PDYNROIV
| Q4 25 | -526.2% | -10076.0% | ||
| Q3 25 | -776.0% | -12317.8% | ||
| Q2 25 | — | -9604.5% | ||
| Q1 25 | -445.0% | 438.1% | ||
| Q4 24 | -3008.1% | -2318.5% | ||
| Q3 24 | -517.8% | -5984.4% | ||
| Q2 24 | -218.9% | -2425.5% | ||
| Q1 24 | -212.1% | -376.1% |
资本支出强度PDYNROIV
| Q4 25 | 14.2% | 246.9% | ||
| Q3 25 | 44.7% | 499.6% | ||
| Q2 25 | 0.0% | 185.9% | ||
| Q1 25 | 5.4% | -2.0% | ||
| Q4 24 | 34.8% | 20.3% | ||
| Q3 24 | 1.4% | 22.3% | ||
| Q2 24 | 5.3% | 12.1% | ||
| Q1 24 | 1.8% | 1.2% |
现金转化率PDYNROIV
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -0.33× | — | ||
| Q4 24 | — | -1.22× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -2.02× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
